Sphere Fluidics Cyto-Mine next-generation single-cell analysis system

Click2Contact

Sphere Fluidics is releasing a supercharged version of its Cyto-Mine system, designed to offer the latest innovations in single-cell isolation and analysis.

The next-generation Cyto-Mine system will feature enhanced capabilities offering multiplexing and greater assay flexibility to meet users’ requirements; this means users should be able to examine greater numbers of cells and isolate the most valuable ones with high levels of precision. For scientists working in cell line development, protein/antibody discovery, cell and gene therapy or beyond, Sphere Fluidics’ advanced droplet-based microfluidics instruments are designed to help lead the way in cell selection.

Cyto-Mine is a state-of-the-art, automated platform designed to transform biopharmaceutical discovery and cell line development. By incorporating advanced technologies, the system can accelerate and simplify the entire cell line development process, from cell encapsulation and assay integration to high-throughput screening and monoclonality assurance.

To be one of the first to experience the technology and see its potential impact on single-cell workflow, contact Capella Science via (02) 9575 7512, sales@capellascience.com.au or www.capellascience.com.au/are-you-ready-for-the-next-generation-cyto-mine/.